Glukoza 5 Braun

Glukoza 5 Braun is a 5% w/v glucose monohydrate solution for injection, supplied as a sterile intravenous carbohydrate solution. It is a prescription‑only product marketed in the European Union and used as a source of glucose in parenteral nutrition and for rapid correction of low blood sugar. The formulation is isotonic and intended for administration by healthcare professionals in hospital or clinical settings under aseptic technique.

Glukoza 5 Braun is indicated for several clinical situations where an immediate source of glucose is required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Fluid and electrolyte replacement as part of balanced intravenous therapy. - Provision of caloric energy in parenteral nutrition regimens. - Support during peri‑operative fasting or prolonged starvation. - Dilution and compatibility with other intravenous medications as directed.

Adverse reactions to Glukoza 5 Braun are generally related to the intravenous administration of a carbohydrate solution.

Common: - Mild hyperglycemia or transient rise in blood glucose. - Local irritation or pain at the infusion site. - Nausea or mild gastrointestinal discomfort.

Serious: - Severe hyperglycemia with osmotic diuresis. - Allergic reaction such as urticaria, rash, or anaphylaxis. - Electrolyte imbalance, particularly hyponatremia, if administered in large volumes.

When using Glukoza 5 Braun, clinicians should observe specific precautions to minimize risks and ensure safe administration.

- Verify blood glucose level before and during infusion to avoid excessive hyperglycemia. - Adjust infusion rate in patients with impaired renal function or diabetes mellitus. - Use aseptic technique and inspect the solution for particulate matter or discoloration. - Monitor electrolytes, especially sodium and potassium, during prolonged therapy. - Avoid rapid bolus administration unless specifically indicated. - Consider compatibility with other IV drugs; do not mix unless compatibility is established. - Document patient response and any adverse events in the medical record.

Glukoza 5 Braun may interact with other agents administered intravenously, influencing glucose levels or solution stability.

Avoid: - Concurrent high‑dose insulin therapy without glucose monitoring. - Co‑administration with other hypertonic carbohydrate solutions that could cause severe hyperglycemia. - Mixing with calcium‑containing solutions that may precipitate.

Use with caution: - Concurrent use of diuretics that affect fluid balance; monitor electrolytes closely. - Administration alongside medications that require strict pH control, such as certain antibiotics. - Use in patients receiving total parenteral nutrition containing other carbohydrate sources; adjust total glucose load.